New paradigms of myocardial regeneration post-infarction: tissue preservation, cell environment, and pluripotent cell sources.
JACC Cardiovasc Interv., Jan;2(1):1-8 (2009)
Intrinsic cardiac origin of human cardiosphere-derived cells.
Eur. Heart J., Jun (2011)
Comparison of long-term outcomes of drug-eluting stents and bare metal stents for saphenous vein graft stenosis.
Catheter Cardiovasc Interv., May;79(6):903-9 (2012)
Partial restoration of myocardial function and perfusion by cell therapy following myocardial infarction.
Curr. Opin. Cardiol., Nov;19(6):631-7 (2004)
Stem-cell repair of infarcted myocardium: ready for clinical application?
Am Heart Hosp J., 2(2):100-6 (2004)
Increasing high-density lipoprotein cholesterol in dyslipidemia by cholesteryl ester transfer protein inhibition: an update for clinicians.
Circulation., Apr;111(14):1847-54 (2005)
Persistence of inflammatory cytokines cause a spectrum of chronic progressive diseases: implications for therapy.
Med. Hypotheses., 65(2):227-31 (2005)
Comparison of drug-eluting stents with bare metal stents in unselected patients with acute myocardial infarction.
Catheter Cardiovasc Interv., Jul;70(1):1-8 (2007)
Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis.
JACC Cardiovasc Interv., Jun;1(3):236-45 (2008)
Prevention of plaque rupture: a new paradigm of therapy.
Ann. Intern. Med., Nov;137(10):823-33 (2002)
Usefulness of left ventricular mass in predicting recovery of left ventricular systolic function in patients with symptomatic idiopathic dilated cardiomyopathy.
Am. J. Cardiol., Mar;85(5):624-9 (2000)
Role of plaque rupture in acute coronary syndromes.
Am. J. Cardiol., Oct;86(8B):15J-23J (2000)
Triglycerides: risk factor or fellow traveler?
Curr. Opin. Cardiol., Jul;16(4):261-4 (2001)
Stem cell repair of infarcted myocardium: an overview for clinicians.
Circulation., Sep;108(9):1139-45 (2003)
28th Bethesda Conference. Task Force 5: Assessment, approval, and regulation of new technology.
J. Am. Coll. Cardiol., May;29(6):1171-9 (1997)
The secondary prevention of coronary artery disease.
Am. J. Med., Jun;102(6):572-81 (1997)
Lipid lowering versus revascularization: an idea whose time (for testing) has come.
Circulation., Aug;96(4):1360-2 (1997)
Aortic smooth muscle cells interact with tenascin-C through its fibrinogen-like domain.
J. Biol. Chem., Dec;272(52):32798-803 (1997)
Bloody pericardial effusion in patients with cardiac tamponade: is the cause cancerous, tuberculous, or iatrogenic in the 1990s?
Chest., Dec;116(6):1564-9 (1999)
Transcutaneous ultrasound augments lysis of arterial thrombi in vivo.
Circulation., Aug;94(4):775-8 (1996)